Anand, D. (2026) “Cardiometabolic Effectiveness and Safety of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus at High Cardiovascular Risk: A Prospective Observational Study”, Adolescência e Saúde, pp. 454–458. Available at: https://adolescenciaesaude.com/index.php/aes/article/view/2007 (Accessed: 9 September 2026).